Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid and Cannabinoid Interactions on Drug Self-Administration
NCT05485012Phase 1Completed
- Start
- Aug 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabis and oxycodone in cannabis use disorder (CUD) and opioid use disorder (OUD) (2 arms). Primary endpoint: Self-Administration of Drug Units Earned at 6 hours. Started Aug 2023; status: completed.
02
Drugs
cannabisoxycodone
03
Conditions
cannabis use disorder (CUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05485012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05485012.